Detalles de la búsqueda
1.
Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
Br J Surg
; 111(5)2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713611
2.
Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis.
Surg Endosc
; 36(8): 5921-5929, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641697
3.
An Optimal Surgical Approach for Suprapancreatic Area Dissection in Laparoscopic D2 Gastrectomy with Complete Mesogastric Excision.
J Gastrointest Surg
; 24(4): 916-917, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31898108
4.
Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Trials
; 19(1): 432, 2018 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30092843
5.
ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.
Oncotarget
; 7(34): 55449-55457, 2016 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27487151
Resultados
1 -
5
de 5
1
Próxima >
>>